Skip to main content

Table 3 Clinic pathological characteristics of tumors from individuals carrying the BRCA1 mutation c.2900_2901 dupCT (p.Pro968Leufs)

From: Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)

Family.individual Sex Age Tumor Histopathology Stage Grade ER PgR HER2
42.1 F 52 Ov Endometrioid IIIC - - - -
42.5 F 82 Ov Serous IIIC - - - -
72.1 F 54 Ov Undifferentiated/Mucinous IC 3 - - -
72.2 F 33 Br Undifferentiated IIIA 3 Neg Neg Neg
215.1 F 41 Ov Serous IIIC 3 - - -
263.1 F 56 Ov Serous IIIB 2 - - -
458.1 F 43 Br IDC II 3 Neg Neg Neg
458.2 F 51 Br IDC III 3 Neg Neg Neg
572.1 F 41 Ov Serous IIIC - - - -
704.1 F 49 Br IDC IIIA - Neg Neg -
828.1 F 48 Br IDC I - Pos Pos -
   78 Br IDC IA 3 Pos Pos Neg
828.2 F 42 Br IDC IIA 3 Pos Pos -
828.3 F 45 Ov - - - - - -
  1. Age age of cancer diagnosis, F female, Br breast cancer, Ov ovarian cancer, IDC invasive ductal carcinoma, ER estrogen receptor status, PR progesterone receptor status, Her2 Her2Neu status, - not applicable or no data, Neg negative, Pos positive.